Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Researchers have discovered how choice of diet can weaken a person's gut immune system and lead to the development of diabetes.
The gut immune system protects us from potential infections and bad reactions to the food we eat. A growing body of research supports that during obesity, our immune system is often responding to components of bacteria that "leak" through the intestinal tissue and results in inflammation. In turn, inflammation can drive insulin resistance, which predisposes people to diabetes.
Dr. Dan Winer, Scientist, Toronto General Hospital Research Institute and the Department of Pathology at UHN, has long been interested in the role the gut plays in diabetes.
In his latest research,
published in Nature Communications this week, Dr. Winer and his team, including graduate students Helen Luck and Saad Khan, and co-lead author, Dr. Shawn Winer at St. Michael's Hospital, highlight how a high fat diet influences one component of the gut immune system called B cells, specifically those that produce a protein called IgA.
"We discovered that during obesity, there are lower levels of a type of B cell in the gut that make an antibody called IgA," said lead author Helen Luck.
"IgA is naturally produced by our bodies and is crucial to regulating the bacteria that live in our gut. It acts as a defense mechanism that helps neutralize potentially dangerous bacteria that take advantage of changes to the environment, such as when we consume an imbalanced or fatty diet."
In their experiments, they also observed that IgA deficient pre-clinical models, which lack protective IgA, had worsened blood sugar levels when fed a high fat diet. As well, transplantation of gut bacteria from these IgA deficient models into models that had no gut bacteria was able to transfer the disease, demonstrating that IgA can regulate the amounts of harmful bacteria in the gut during diet-related obesity.
The team also found that the bacteria within the intestines of the obese IgA deficient models were physically closer to the intestinal wall, and thus more likely to breach it. These models also had a leakier gut lining which resulted in more inflammation seen in the gut and fat tissue, big risk factors for insulin resistance and diabetes.
In collaboration with a bariatric surgery research team at UHN led by Dr. Johane Allard and Dr. Herbert Gaisano, the team saw increased levels of IgA within the stool of patients soon after bariatric surgery, supporting the importance of IgA and the gut immune system in humans with obesity.
Overall, the research highlights a robust connection between high fat diets, obesity and the lack of gut IgA in promoting inflammation and insulin resistance. The knowledge that this class of antibodies regulate pathogenic bacteria, and protects against a "leaky gut" and additional complications of obesity, is a powerful tool in the fight against diabetes.
"If we can boost these IgA B cells or their products, then we may be able to control the type of bacteria in the gut," says Dr. Winer. "Especially the ones that are more likely to be linked to inflammation and ultimately insulin resistance.
"Going forward, this work could form the basis for new gut immune biomarkers or therapies for obesity and its complications, like insulin resistance and type 2 diabetes."